IMMUNOTHERAPY-INDUCED PNEUMONITIS

Clinical trials for IMMUNOTHERAPY-INDUCED PNEUMONITIS explained in plain language.

Never miss a new study

Get alerted when new IMMUNOTHERAPY-INDUCED PNEUMONITIS trials appear

Sign up with your email to follow new studies for IMMUNOTHERAPY-INDUCED PNEUMONITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Deep-Breathing device may shield lung cancer patients from pneumonitis

Symptom relief Recruiting now

This study tests whether using an incentive spirometer—a device that encourages deep breathing—can lower the risk of lung inflammation (pneumonitis) in people with advanced lung cancer receiving chemotherapy and radiation. About 100 participants will use the device 10 times every…

Matched conditions: IMMUNOTHERAPY-INDUCED PNEUMONITIS

Phase: NA • Sponsor: The Cooper Health System • Aim: Symptom relief

Last updated May 07, 2026 18:39 UTC

IMMUNOTHERAPY-INDUCED PNEUMONITIS

Get alerted when new IMMUNOTHERAPY-INDUCED PNEUMONITIS trials appear

Deep-Breathing device may shield lung cancer patients from pneumonitis